Fundraising Fox

Vima Therapeutics, Inc.

26 employees on LinkedIn · 5 known investors

Vima Therapeutics is a biotech company developing drug treatments for movement disorders such as dystonia and related neurological diseases. It is run by a team of physicians, scientists, and drug-development specialists focused on neurological conditions.

BiotechHealthtechMedical Devices

Founders & leadership

BRBernard Ravina
Bernard RavinainFounder and Chief Executive Officer
JDJudy Dunn
Judy DunnPresident of Research & Development
JFJessica Fees
Jessica FeesinChief Financial Officer
ADAriel D. Jasie
Ariel D. JasieinChief Business Officer and General Counsel
TMTushar Misra
Tushar MisrainChief Technical Officer

Investors · 5

Atlas Venture✓ verifiedCambridge · $500K – $1M
Frazier Life Sciences✓ verifiedPalo Alto
Access Industries✓ verifiedNew York
Access BiotechnologyNew York City
Canaan PartnersStamford · $500K – $20M

Frequently asked questions

What does Vima Therapeutics, Inc. do?
Vima Therapeutics is a biotech company developing drug treatments for movement disorders such as dystonia and related neurological diseases. It is run by a team of physicians, scientists, and drug-development specialists focused on neurological conditions.
Who founded Vima Therapeutics, Inc.?
Vima Therapeutics, Inc. was founded by Bernard Ravina.
Who are Vima Therapeutics, Inc.'s investors?
Vima Therapeutics, Inc.'s investors include Atlas Venture, Frazier Life Sciences, Access Industries, Access Biotechnology, Canaan Partners.